Cargando…
Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran
BACKGROUND: Bladder cancer (BC) is the 10th most common type of cancer worldwide and the fourth most common type of cancer in Iran. Opium use is considered as one of the risk factors for BC. We aim to assess the association between various parameters of opium use, which in Iran is mainly ingested or...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189939/ https://www.ncbi.nlm.nih.gov/pubmed/35244716 http://dx.doi.org/10.1093/ije/dyac031 |
_version_ | 1784725696366510080 |
---|---|
author | Hadji, Maryam Rashidian, Hamideh Marzban, Maryam Naghibzadeh-Tahami, Ahmad Gholipour, Mahin Mohebbi, Elham Safari-Faramani, Roya Seyyedsalehi, Monireh Sadat Hosseini, Bayan Bakhshi, Mahdieh Alizadeh-Navaei, Reza Ahmadi, Lida Rezaianzadeh, Abbas Moradi, Abdolvahab Ansari-Moghaddam, Alireza Nejatizadeh, Azim ShahidSales, Soodabeh Zohrabi, Farshad Mohammadi, Reza Nowroozi, Mohammad Reza Poustchi, Hossein Nasrollahzadeh, Dariush Najafi, Farid Haghdoost, Ali Akbar Rahimi-Movaghar, Afarin Etemadi, Arash Mohagheghi, Mohammad Ali Malekzadeh, Reza Brennan, Paul Schüz, Joachim Boffetta, Paolo Weiderpass, Elisabete Kamangar, Farin Zendehdel, Kazem Pukkala, Eero |
author_facet | Hadji, Maryam Rashidian, Hamideh Marzban, Maryam Naghibzadeh-Tahami, Ahmad Gholipour, Mahin Mohebbi, Elham Safari-Faramani, Roya Seyyedsalehi, Monireh Sadat Hosseini, Bayan Bakhshi, Mahdieh Alizadeh-Navaei, Reza Ahmadi, Lida Rezaianzadeh, Abbas Moradi, Abdolvahab Ansari-Moghaddam, Alireza Nejatizadeh, Azim ShahidSales, Soodabeh Zohrabi, Farshad Mohammadi, Reza Nowroozi, Mohammad Reza Poustchi, Hossein Nasrollahzadeh, Dariush Najafi, Farid Haghdoost, Ali Akbar Rahimi-Movaghar, Afarin Etemadi, Arash Mohagheghi, Mohammad Ali Malekzadeh, Reza Brennan, Paul Schüz, Joachim Boffetta, Paolo Weiderpass, Elisabete Kamangar, Farin Zendehdel, Kazem Pukkala, Eero |
author_sort | Hadji, Maryam |
collection | PubMed |
description | BACKGROUND: Bladder cancer (BC) is the 10th most common type of cancer worldwide and the fourth most common type of cancer in Iran. Opium use is considered as one of the risk factors for BC. We aim to assess the association between various parameters of opium use, which in Iran is mainly ingested or smoked in various forms, and the risk of BC. METHOD: In this multi-centre case-referent study in Iran, 717 BC cases and 3477 referents were recruited to the study from May 2017 until July 2020. Detailed histories of opium use (duration, amount, frequency) and potential confounders were collected by trained interviewers. Multivariable unconditional logistic regression models were used to measure adjusted odds ratio (OR) and 95% confidence intervals (CI). The ORs were adjusted for age, gender, place of residence and pack-years of cigarette smoking. RESULTS: Regular opium consumption was associated with an increased risk of BC (OR 3.5, 95% CI: 2.8, 4.3) compared with subjects who never used opium. Compared with continuous users, the risk decreased to one-third for those who stopped opium more than 10 years ago. The adjusted OR for those who used both crude opium (teriak) and opium juice was 7.4 (95% CI: 4.1, 13.3). There was a joint effect of opium and tobacco (OR for users of both opium and tobacco 7.7, 95% CI: 6.0, 9.7). CONCLUSIONS: Regular opium use is associated with an approximately 4-fold risk for BC. The OR decreases along with the increasing time since stopping opium use. |
format | Online Article Text |
id | pubmed-9189939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91899392022-06-14 Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran Hadji, Maryam Rashidian, Hamideh Marzban, Maryam Naghibzadeh-Tahami, Ahmad Gholipour, Mahin Mohebbi, Elham Safari-Faramani, Roya Seyyedsalehi, Monireh Sadat Hosseini, Bayan Bakhshi, Mahdieh Alizadeh-Navaei, Reza Ahmadi, Lida Rezaianzadeh, Abbas Moradi, Abdolvahab Ansari-Moghaddam, Alireza Nejatizadeh, Azim ShahidSales, Soodabeh Zohrabi, Farshad Mohammadi, Reza Nowroozi, Mohammad Reza Poustchi, Hossein Nasrollahzadeh, Dariush Najafi, Farid Haghdoost, Ali Akbar Rahimi-Movaghar, Afarin Etemadi, Arash Mohagheghi, Mohammad Ali Malekzadeh, Reza Brennan, Paul Schüz, Joachim Boffetta, Paolo Weiderpass, Elisabete Kamangar, Farin Zendehdel, Kazem Pukkala, Eero Int J Epidemiol Cancer BACKGROUND: Bladder cancer (BC) is the 10th most common type of cancer worldwide and the fourth most common type of cancer in Iran. Opium use is considered as one of the risk factors for BC. We aim to assess the association between various parameters of opium use, which in Iran is mainly ingested or smoked in various forms, and the risk of BC. METHOD: In this multi-centre case-referent study in Iran, 717 BC cases and 3477 referents were recruited to the study from May 2017 until July 2020. Detailed histories of opium use (duration, amount, frequency) and potential confounders were collected by trained interviewers. Multivariable unconditional logistic regression models were used to measure adjusted odds ratio (OR) and 95% confidence intervals (CI). The ORs were adjusted for age, gender, place of residence and pack-years of cigarette smoking. RESULTS: Regular opium consumption was associated with an increased risk of BC (OR 3.5, 95% CI: 2.8, 4.3) compared with subjects who never used opium. Compared with continuous users, the risk decreased to one-third for those who stopped opium more than 10 years ago. The adjusted OR for those who used both crude opium (teriak) and opium juice was 7.4 (95% CI: 4.1, 13.3). There was a joint effect of opium and tobacco (OR for users of both opium and tobacco 7.7, 95% CI: 6.0, 9.7). CONCLUSIONS: Regular opium use is associated with an approximately 4-fold risk for BC. The OR decreases along with the increasing time since stopping opium use. Oxford University Press 2022-03-04 /pmc/articles/PMC9189939/ /pubmed/35244716 http://dx.doi.org/10.1093/ije/dyac031 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the International Epidemiological Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Cancer Hadji, Maryam Rashidian, Hamideh Marzban, Maryam Naghibzadeh-Tahami, Ahmad Gholipour, Mahin Mohebbi, Elham Safari-Faramani, Roya Seyyedsalehi, Monireh Sadat Hosseini, Bayan Bakhshi, Mahdieh Alizadeh-Navaei, Reza Ahmadi, Lida Rezaianzadeh, Abbas Moradi, Abdolvahab Ansari-Moghaddam, Alireza Nejatizadeh, Azim ShahidSales, Soodabeh Zohrabi, Farshad Mohammadi, Reza Nowroozi, Mohammad Reza Poustchi, Hossein Nasrollahzadeh, Dariush Najafi, Farid Haghdoost, Ali Akbar Rahimi-Movaghar, Afarin Etemadi, Arash Mohagheghi, Mohammad Ali Malekzadeh, Reza Brennan, Paul Schüz, Joachim Boffetta, Paolo Weiderpass, Elisabete Kamangar, Farin Zendehdel, Kazem Pukkala, Eero Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran |
title | Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran |
title_full | Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran |
title_fullStr | Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran |
title_full_unstemmed | Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran |
title_short | Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran |
title_sort | opium use and risk of bladder cancer: a multi-centre case-referent study in iran |
topic | Cancer |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189939/ https://www.ncbi.nlm.nih.gov/pubmed/35244716 http://dx.doi.org/10.1093/ije/dyac031 |
work_keys_str_mv | AT hadjimaryam opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT rashidianhamideh opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT marzbanmaryam opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT naghibzadehtahamiahmad opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT gholipourmahin opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT mohebbielham opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT safarifaramaniroya opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT seyyedsalehimonirehsadat opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT hosseinibayan opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT bakhshimahdieh opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT alizadehnavaeireza opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT ahmadilida opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT rezaianzadehabbas opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT moradiabdolvahab opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT ansarimoghaddamalireza opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT nejatizadehazim opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT shahidsalessoodabeh opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT zohrabifarshad opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT mohammadireza opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT nowroozimohammadreza opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT poustchihossein opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT nasrollahzadehdariush opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT najafifarid opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT haghdoostaliakbar opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT rahimimovagharafarin opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT etemadiarash opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT mohagheghimohammadali opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT malekzadehreza opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT brennanpaul opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT schuzjoachim opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT boffettapaolo opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT weiderpasselisabete opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT kamangarfarin opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT zendehdelkazem opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran AT pukkalaeero opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran |